VIRGIN MONEY UK PLC
(Company or Virgin Money)
LEI: 213800ZK9VGCYYR6O495
20 December 2022
External Appointment
Pursuant to the Financial Conduct Authority's Listing Rule 9.6.14R(2) the Company notifies the market that, as announced by Dechra Pharmaceuticals PLC (Dechra) on 20 December 2022, Geeta Gopalan, an independent non-executive director of the Company, is to be appointed as a non-executive director of Dechra with effect from 1 January 2023. Geeta will be a member of the Audit, Remuneration and Nomination Committees of Dechra with the intention that she will be appointed as Chair of the Remuneration Committee of Dechra from 1 March 2023.
Announcement authorised for release by Lorna McMillan, Group Company Secretary.
For further information, please contact:
|
Investors and Analysts |
|
|
Richard Smith |
07483 399303 |
|
Head of Investor Relations |
richard.smith@virginmoneyukplc.com |
|
|
|
|
Company Secretary |
|
|
Lorna McMillan |
07834 585436 |
|
Group Company Secretary |
lorna.mcmillan@virginmoneyukplc.com |
|
|
|
|
Media Relations |
|
|
Press Office |
0800 066 5998 |
|
|
press.office@virginmoneyukplc.com |
Virgin Money UK PLC is registered in England and Wales (company number: 09595911) and as a foreign company in Australia (ARBN 609 948 281) and has its registered office at Jubilee House, Gosforth, Newcastle upon Tyne, NE3 4PL
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
